Loading...
Header Logo
Keywords
Last Name
Institution

Dr Marie-Paule Kieny

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Modjarrad K, Moorthy VS, Millett P, Gsell PS, Roth C, Kieny MP. Developing Global Norms for Sharing Data and Results during Public Health Emergencies. PLoS Med. 2016 Jan; 13(1):e1001935. PMID: 26731342; PMCID: PMC4701443.
    2. Tiffay K, Jodar L, Kieny MP, Socquet M, LaForce FM. The Evolution of the Meningitis Vaccine Project. Clin Infect Dis. 2015 Nov 15; 61 Suppl 5:S396-403. PMID: 26553666; PMCID: PMC4639496.
    3. Tapia MD, Sow SO, Lyke KE, Haidara FC, Diallo F, Doumbia M, Traore A, Coulibaly F, Kodio M, Onwuchekwa U, Sztein MB, Wahid R, Campbell JD, Kieny MP, Moorthy V, Imoukhuede EB, Rampling T, Roman F, De Ryck I, Bellamy AR, Dally L, Mbaya OT, Ploquin A, Zhou Y, Stanley DA, Bailer R, Koup RA, Roederer M, Ledgerwood J, Hill AVS, Ballou WR, Sullivan N, Graham B, Levine MM. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2016 Jan; 16(1):31-42. PMID: 26546548; PMCID: PMC4700389.
    4. Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, Kaya G, Krähling V, Kwilas S, Lemaître B, Matthey A, Silvera P, Becker S, Fast PE, Moorthy V, Kieny MP, Kaiser L, Siegrist CA. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infect Dis. 2015 Oct; 15(10):1156-66. PMID: 26248510.
      View in: PubMed
    5. Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé MK, Kone S, Kuisma E, Levine MM, Mandal S, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Watson CH, Kéïta S, Kieny MP, Røttingen JA. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015 Aug 29; 386(9996):857-66. PMID: 26248676.
      View in: PubMed
    6. Bishai D, Ghaffar A, Kelley E, Kieny MP. Honouring the value of people in public health: a different kind of p-value. Bull World Health Organ. 2015 Sep 01; 93(9):661-2. PMID: 26478631; PMCID: PMC4581643.
    7. Moorthy VS, Karam G, Vannice KS, Kieny MP. Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results. PLoS Med. 2015 Apr; 12(4):e1001819. PMID: 25874642; PMCID: PMC4396122.
    8. Magrini N, Robertson J, Forte G, Cappello B, Moja LP, de Joncheere K, Kieny MP. Tough decisions on essential medicines in 2015. Bull World Health Organ. 2015 Apr 01; 93(4):283-4. PMID: 26229193; PMCID: PMC4431566.
    9. Schenkelberg T, Kieny MP, Bianco AE, Koff WC. Building the Human Vaccines Project: strategic management recommendations and summary report of the 15-16 July 2014 business workshop. Expert Rev Vaccines. 2015 May; 14(5):629-36. PMID: 25673514.
      View in: PubMed
    10. Adam T, Røttingen JA, Kieny MP. Informing the establishment of the WHO Global Observatory on Health Research and Development: a call for papers. Health Res Policy Syst. 2015 Feb 02; 13:9. PMID: 25645000; PMCID: PMC4328039.
    11. Kieny MP, Dovlo D. Beyond Ebola: a new agenda for resilient health systems. Lancet. 2015 Jan 10; 385(9963):91-2. PMID: 25706456.
      View in: PubMed
    12. Ghaffar A, Tran N, Røttingen JA, Kieny MP. Health policy and systems research: building momentum and community. Bull World Health Organ. 2014 Dec 01; 92(12):851. PMID: 25552766; PMCID: PMC4264400.
    13. Kieny MP, Evans DB, Schmets G, Kadandale S. Health-system resilience: reflections on the Ebola crisis in western Africa. Bull World Health Organ. 2014 Dec 01; 92(12):850. PMID: 25552765; PMCID: PMC4264399.
    14. Kanapathipillai R, Henao Restrepo AM, Fast P, Wood D, Dye C, Kieny MP, Moorthy V. Ebola vaccine--an urgent international priority. N Engl J Med. 2014 Dec 11; 371(24):2249-51. PMID: 25289888.
      View in: PubMed
    15. Boerma T, Eozenou P, Evans D, Evans T, Kieny MP, Wagstaff A. Monitoring progress towards universal health coverage at country and global levels. PLoS Med. 2014 Sep; 11(9):e1001731. PMID: 25243899; PMCID: PMC4171369.
    16. Krech R, Kieny MP. The 2014 Ebola outbreak: ethical use of unregistered interventions. Bull World Health Organ. 2014 Sep 01; 92(9):622. PMID: 25378748; PMCID: PMC4208580.
    17. Briand S, Bertherat E, Cox P, Formenty P, Kieny MP, Myhre JK, Roth C, Shindo N, Dye C. The international Ebola emergency. N Engl J Med. 2014 Sep 25; 371(13):1180-3. PMID: 25140855.
      View in: PubMed
    18. Evans DB, Boerma T, Kieny MP. Monitoring progress towards universal health coverage: recent developments. East Mediterr Health J. 2014 Aug 19; 20(8):475-6. PMID: 25150353.
      View in: PubMed
    19. Sales M, Kieny MP, Krech R, Etienne C. Human resources for universal health coverage: from evidence to policy and action. Bull World Health Organ. 2013 Nov 01; 91(11):798-798A. PMID: 24347697; PMCID: PMC3853969.
    20. Kieny MP, Evans DB. Universal health coverage. East Mediterr Health J. 2013 Apr; 19(4):305-6. PMID: 23882953.
      View in: PubMed
    21. Mihigo R, Torrealba CV, Coninx K, Nshimirimana D, Kieny MP, Carrasco P, Hedman L, Widdowson MA. 2009 Pandemic influenza A virus subtype H1N1 vaccination in Africa--successes and challenges. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S22-8. PMID: 23169967.
      View in: PubMed
    22. Partridge J, Kieny MP. Global production capacity of seasonal influenza vaccine in 2011. Vaccine. 2013 Jan 21; 31(5):728-31. PMID: 23149268.
      View in: PubMed
    23. Ghaffar A, Tran N, Kieny MP, Etienne C. Putting health policy and systems research on the map. Bull World Health Organ. 2012 Nov 01; 90(11):797-797A. PMID: 23226888; PMCID: PMC3506411.
    24. Kraushaar D, Kieny MP, Lazarus JV, Bermejo R, Abimbola S, Prashanth N, Flores W, Ssengooba F, Maceira D. Health Systems Global, the new international society for health systems research. Health Policy Plan. 2012 Oct; 27(7):535-40. PMID: 23045410.
      View in: PubMed
    25. Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis. 2012 Nov; 12(11):837-44. PMID: 22954655.
      View in: PubMed
    26. Hashim R, Khatib AM, Enwere G, Park JK, Reyburn R, Ali M, Chang NY, Kim DR, Ley B, Thriemer K, Lopez AL, Clemens JD, Deen JL, Shin S, Schaetti C, Hutubessy R, Aguado MT, Kieny MP, Sack D, Obaro S, Shaame AJ, Ali SM, Saleh AA, von Seidlein L, Jiddawi MS. Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. PLoS Negl Trop Dis. 2012; 6(7):e1743. PMID: 22848772; PMCID: PMC3404114.
    27. Tam JS, Barbeschi M, Shapovalova N, Briand S, Memish ZA, Kieny MP. Research agenda for mass gatherings: a call to action. Lancet Infect Dis. 2012 Mar; 12(3):231-9. PMID: 22252148.
      View in: PubMed
    28. Stittelaar KJ, Veldhuis Kroeze EJ, Rudenko L, Dhere R, Thirapakpoomanunt S, Kieny MP, Osterhaus AD. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets. Vaccine. 2011 Nov 15; 29(49):9265-70. PMID: 21945964.
      View in: PubMed
    29. Friede M, Palkonyay L, Alfonso C, Pervikov Y, Torelli G, Wood D, Kieny MP. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer. Vaccine. 2011 Jul 01; 29 Suppl 1:A2-7. PMID: 21684422.
      View in: PubMed
    30. Girard MP, Osmanov S, Assossou OM, Kieny MP. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review. Vaccine. 2011 Aug 26; 29(37):6191-218. PMID: 21718747.
      View in: PubMed
    31. Pourbohloul B, Kieny MP. Complex systems analysis: towards holistic approaches to health systems planning and policy. Bull World Health Organ. 2011 Apr 01; 89(4):242. PMID: 21479083; PMCID: PMC3066532.
    32. Girard MP, Katz J, Pervikov Y, Palkonyay L, Kieny MP. Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010. Vaccine. 2010 Oct 04; 28(42):6811-20. PMID: 20659520.
      View in: PubMed
    33. Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine. 2010 Jul 12; 28(31):4895-902. PMID: 20553769.
      View in: PubMed
    34. Partridge J, Kieny MP. Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine. 2010 Jul 05; 28(30):4709-12. PMID: 20488262.
      View in: PubMed
    35. Stephenson I, Hayden F, Osterhaus A, Howard W, Pervikov Y, Palkonyay L, Kieny MP. Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009. Vaccine. 2010 May 21; 28(23):3875-82. PMID: 20398616.
      View in: PubMed
    36. Moorthy VS, Kieny MP. Reducing empiricism in malaria vaccine design. Lancet Infect Dis. 2010 Mar; 10(3):204-11. PMID: 20185099.
      View in: PubMed
    37. Müller T, Dietzschold B, Ertl H, Fooks AR, Freuling C, Fehlner-Gardiner C, Kliemt J, Meslin FX, Franka R, Rupprecht CE, Tordo N, Wanderler AI, Kieny MP. Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl Trop Dis. 2009 Nov 03; 3(11):e542. PMID: 19888334; PMCID: PMC2765635.
    38. Kieny MP. WHO supports fair access to influenza A (H1N1) vaccine. Bull World Health Organ. 2009 Sep; 87(9):653-4. PMID: 19784443; PMCID: PMC2739921.
    39. Gryseels B, Zumla A, Troye-Blomberg M, Kieny MP, Quaglio G, Holtel A, Laang H, Romaris M, De Magistris MT, Nuez AN, Olesen OF, Ghalouci R, Lönnroth A. European Union conference on poverty-related diseases research. Lancet Infect Dis. 2009 Jun; 9(6):334-7. PMID: 19467472.
      View in: PubMed
    40. Hayden FG, Howard WA, Palkonyay L, Kieny MP. Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009. Vaccine. 2009 Jun 24; 27(31):4079-89. PMID: 19406184.
      View in: PubMed
    41. Moorthy V, Smith PG, Kieny MP. A vaccine against malaria: a substantial step forward. Lancet. 2009 Apr 25; 373(9673):1411-2. PMID: 19394521.
      View in: PubMed
    42. Reed ZH, Kieny MP, Engers H, Friede M, Chang S, Longacre S, Malhotra P, Pan W, Long C. Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits. Vaccine. 2009 Mar 04; 27(10):1651-60. PMID: 19038302.
      View in: PubMed
    43. Friede M, Serdobova I, Palkonyay L, Kieny MP. Technology transfer hub for pandemic influenza vaccine. Vaccine. 2009 Jan 29; 27(5):631-2. PMID: 19022316.
      View in: PubMed
    44. Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Kieny MP, Tanner M. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine. 2008 Dec 09; 26(52):6759-67. PMID: 18950671.
      View in: PubMed
    45. Launois P, Tacchini-Cottier F, Kieny MP. Cutaneous leishmaniasis: progress towards a vaccine. Expert Rev Vaccines. 2008 Oct; 7(8):1277-87. PMID: 18844599.
      View in: PubMed
    46. Kieny MP, Fukuda K. The pandemic influenza vaccine challenge. Vaccine. 2008 Sep 12; 26 Suppl 4:D3-4. PMID: 19230152.
      View in: PubMed
    47. Trotter CL, McVernon J, Ramsay ME, Whitney CG, Mulholland EK, Goldblatt D, Hombach J, Kieny MP. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine. 2008 Aug 18; 26(35):4434-45. PMID: 18617296.
      View in: PubMed
    48. Girard M, Palkonyay L, Kieny MP. Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials." World Health Organization, Geneva, Switzerland, 14-15 February 2008. Vaccine. 2008 Sep 15; 26(39):4975-7. PMID: 18514979.
      View in: PubMed
    49. Chaignat CL, Monti V, Soepardi J, Petersen G, Sorensen E, Narain J, Kieny MP. Cholera in disasters: do vaccines prompt new hopes? Expert Rev Vaccines. 2008 May; 7(4):431-5. PMID: 18444890.
      View in: PubMed
    50. Hu J, Chen Z, Gu J, Wan M, Shen Q, Kieny MP, He J, Li Z, Zhang Q, Reed ZH, Zhu Y, Li W, Cao Y, Qu L, Cao Z, Wang Q, Liu H, Pan X, Huang X, Zhang D, Xue X, Pan W. Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults. PLoS One. 2008 Apr 09; 3(4):e1952. PMID: 18398475; PMCID: PMC2276862.
    51. Girard MP, Osterhaus A, Pervikov Y, Palkonyay L, Kieny MP. Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007. Vaccine. 2008 May 12; 26(20):2443-50. PMID: 18420316.
      View in: PubMed
    52. Thumann C, Schvoerer E, Abraham JD, Bohbot A, Stoll-Keller F, Aubertin AM, Kieny MP. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation. Gastroenterol Clin Biol. 2008 Jan; 32(1 Pt. 1):59-68. PMID: 18341978.
      View in: PubMed
    53. Paul S, Geist M, Dott K, Snary D, Taylor-Papadimitriou J, Acres B, Silvestre N, Kieny MP, Balloul JM. Specific tumor cell targeting by a recombinant MVA expressing a functional single chain antibody on the surface of intracellular mature virus (IMV) particles. Viral Immunol. 2007 Dec; 20(4):664-71. PMID: 18158739.
      View in: PubMed
    54. Kieny MP, LaForce FM. The promise of conjugate vaccines for Africa. Vaccine. 2007 Sep 03; 25 Suppl 1:A108-10. PMID: 17548136.
      View in: PubMed
    55. Nelson CB, Birmingham M, Costa A, Daviaud J, Perea W, Kieny MP, Tarantola D. Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine. Am J Public Health. 2007 Apr; 97 Suppl 1:S15-22. PMID: 17413077; PMCID: PMC1854992.
    56. Tarantola D, Macklin R, Reed ZH, Kieny MP, Osmanov S, Stobie M, Hankins C. Ethical considerations related to the provision of care and treatment in vaccine trials. Vaccine. 2007 Jun 21; 25(26):4863-74. PMID: 17466418.
      View in: PubMed
    57. Fukuda K, Kieny MP. Different approaches to influenza vaccination. N Engl J Med. 2006 Dec 14; 355(24):2586-7. PMID: 17167142.
      View in: PubMed
    58. Girard MP, Reed ZH, Friede M, Kieny MP. A review of human vaccine research and development: malaria. Vaccine. 2007 Feb 19; 25(9):1567-80. PMID: 17045367.
      View in: PubMed
    59. Kieny MP, Costa A, Hombach J, Carrasco P, Pervikov Y, Salisbury D, Greco M, Gust I, LaForce M, Franco-Paredes C, Santos JI, D'Hondt E, Rimmelzwaan G, Karron R, Fukuda K. A global pandemic influenza vaccine action plan. Vaccine. 2006 Sep 29; 24(40-41):6367-70. PMID: 17240560.
      View in: PubMed
    60. Codran A, Royer C, Jaeck D, Bastien-Valle M, Baumert TF, Kieny MP, Pereira CA, Martin JP. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. J Gen Virol. 2006 Sep; 87(Pt 9):2583-93. PMID: 16894197.
      View in: PubMed
    61. Stöhr K, Kieny MP, Wood D. Influenza pandemic vaccines: how to ensure a low-cost, low-dose option. Nat Rev Microbiol. 2006 Aug; 4(8):565-6. PMID: 16888876.
      View in: PubMed
    62. Stephenson I, Gust I, Pervikov Y, Kieny MP. Development of vaccines against influenza H5. Lancet Infect Dis. 2006 Aug; 6(8):458-60. PMID: 16870521.
      View in: PubMed
    63. Serdobova I, Kieny MP. Assembling a global vaccine development pipeline for infectious diseases in the developing world. Am J Public Health. 2006 Sep; 96(9):1554-9. PMID: 16873743; PMCID: PMC1551949.
    64. Milstien JB, Kaddar M, Kieny MP. The impact of globalization on vaccine development and availability. Health Aff (Millwood). 2006 Jul-Aug; 25(4):1061-9. PMID: 16835187.
      View in: PubMed
    65. Hampson AW, Osterhaus AD, Pervikov Y, Kieny MP. Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005. Vaccine. 2006 Jun 05; 24(23):4897-4900. PMID: 16823947.
      View in: PubMed
    66. Girard MP, Preziosi MP, Aguado MT, Kieny MP. A review of vaccine research and development: meningococcal disease. Vaccine. 2006 May 29; 24(22):4692-700. PMID: 16621189.
      View in: PubMed
    67. Reed ZH, Friede M, Kieny MP. Malaria vaccine development: progress and challenges. Curr Mol Med. 2006 Mar; 6(2):231-45. PMID: 16515513.
      View in: PubMed
    68. Girard MP, Osmanov SK, Kieny MP. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine. 2006 May 08; 24(19):4062-81. PMID: 16530298.
      View in: PubMed
    69. Stephenson I, Gust I, Kieny MP, Pervikov Y. Development and evaluation of influenza pandemic vaccines. Lancet Infect Dis. 2006 Feb; 6(2):71-2. PMID: 16439326.
      View in: PubMed
    70. Girard MP, Steele D, Chaignat CL, Kieny MP. A review of vaccine research and development: human enteric infections. Vaccine. 2006 Apr 05; 24(15):2732-50. PMID: 16483695.
      View in: PubMed
    71. Kieny MP, Girard MP. Human vaccine research and development: an overview. Vaccine. 2005 Dec 30; 23(50):5705-7. PMID: 16182415.
      View in: PubMed
    72. Girard MP, Fruth U, Kieny MP. A review of vaccine research and development: tuberculosis. Vaccine. 2005 Dec 30; 23(50):5725-31. PMID: 16153751.
      View in: PubMed
    73. Girard MP, Cherian T, Pervikov Y, Kieny MP. A review of vaccine research and development: human acute respiratory infections. Vaccine. 2005 Dec 30; 23(50):5708-24. PMID: 16154667.
      View in: PubMed
    74. Hombach J, Barrett AD, Cardosa MJ, Deubel V, Guzman M, Kurane I, Roehrig JT, Sabchareon A, Kieny MP. Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand. Vaccine. 2005 Apr 15; 23(21):2689-95. PMID: 15841565.
      View in: PubMed
    75. Siavoshian S, Abraham JD, Thumann C, Kieny MP, Schuster C. Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells. J Med Virol. 2005 Mar; 75(3):402-11. PMID: 15648076.
      View in: PubMed
    76. Aguado T, Bertherat E, Djingarey M, Kandolo D, Kieny MP, Kondé K, LaForce FM, Nelson CB, Perea W, Préziosi MP. Meningococcal meningitis. Nat Rev Microbiol. 2005 Jan; 3(1):10-1. PMID: 15635779.
      View in: PubMed
    77. Kieny MP, Excler JL, Girard M. Research and development of new vaccines against infectious diseases. Am J Public Health. 2004 Nov; 94(11):1931-5. PMID: 15514230; PMCID: PMC1448562.
    78. Abraham JD, Himoudi N, Kien F, Berland JL, Codran A, Bartosch B, Baumert T, Paranhos-Baccala G, Schuster C, Inchauspé G, Kieny MP. Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins. Vaccine. 2004 Sep 28; 22(29-30):3917-28. PMID: 15364440.
      View in: PubMed
    79. Pink JR, Kieny MP. 4th meeting on Novel Adjuvants Currently in/close to Human Clinical Testing World Health Organization -- organisation Mondiale de la Santé Fondation Mérieux, Annecy, France, 23-25, June 2003. Vaccine. 2004 Jun 02; 22(17-18):2097-102. PMID: 15212010.
      View in: PubMed
    80. Siavoshian S, Abraham JD, Kieny MP, Schuster C. HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines. Arch Virol. 2004 Feb; 149(2):323-36. PMID: 14745598.
      View in: PubMed
    81. Li J, Li W, Liang S, Cai D, Kieny MP, Jacob L, Linnenbach A, Abramczuk JW, Bender H, Sproesser K, Swoboda R, Somasundaram R, Guerry D, Herlyn D. Recombinant CD63/ME491/neuroglandular/NKI/C-3 antigen inhibits growth of established tumors in transgenic mice. J Immunol. 2003 Sep 15; 171(6):2922-9. PMID: 12960315.
      View in: PubMed
    82. Engers H, Kieny MP, Malhotra P, Pink JR. Third meeting on Novel Adjuvants Currently in or Close to Clinical Testing World Health Organization--Organisation Mondiale de la Santé, Fondation Mérieux, Annecy, France, 7-9 January 2002. Vaccine. 2003 Sep 08; 21(25-26):3503-24. PMID: 14518430.
      View in: PubMed
    83. Duclos P, Delo A, Aguado T, Bilous J, Birmingham M, Kieny MP, Milstien J, Wood D, Tarantola D. Immunization safety priority project at the World Health Organization. Semin Pediatr Infect Dis. 2003 Jul; 14(3):233-9. PMID: 12913836.
      View in: PubMed
    84. Imbert I, Dimitrova M, Kien F, Kieny MP, Schuster C. Hepatitis C virus IRES efficiency is unaffected by the genomic RNA 3'NTR even in the presence of viral structural or non-structural proteins. J Gen Virol. 2003 Jun; 84(Pt 6):1549-57. PMID: 12771425.
      View in: PubMed
    85. Dimitrova M, Imbert I, Kieny MP, Schuster C. Protein-protein interactions between hepatitis C virus nonstructural proteins. J Virol. 2003 May; 77(9):5401-14. PMID: 12692242; PMCID: PMC153952.
    86. Kien F, Abraham JD, Schuster C, Kieny MP. Analysis of the subcellular localization of hepatitis C virus E2 glycoprotein in live cells using EGFP fusion proteins. J Gen Virol. 2003 Mar; 84(Pt 3):561-6. PMID: 12604806.
      View in: PubMed
    87. Kieny MP. [Malaria vaccines: state of advancement]. Med Trop (Mars). 2003; 63(3):245-6. PMID: 14579460.
      View in: PubMed
    88. Himoudi N, Abraham JD, Fournillier A, Lone YC, Joubert A, Op De Beeck A, Freida D, Lemonnier F, Kieny MP, Inchauspé G. Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection. J Virol. 2002 Dec; 76(24):12735-46. PMID: 12438599; PMCID: PMC136695.
    89. Schuster C, Isel C, Imbert I, Ehresmann C, Marquet R, Kieny MP. Secondary structure of the 3' terminus of hepatitis C virus minus-strand RNA. J Virol. 2002 Aug; 76(16):8058-68. PMID: 12134011; PMCID: PMC155128.
    90. Paul S, Regulier E, Rooke R, Stoeckel F, Geist M, Homann H, Balloul JM, Villeval D, Poitevin Y, Kieny MP, Acres RB. Tumor gene therapy by MVA-mediated expression of T-cell-stimulating antibodies. Cancer Gene Ther. 2002 May; 9(5):470-7. PMID: 11961670.
      View in: PubMed
    91. Zaloudik J, Li W, Jacob L, Kieny MP, Somasundaram R, Acres B, Song H, Zhang T, Li J, Herlyn D. Inhibition of tumor growth by recombinant vaccinia virus expressing GA733/CO17-1A/EpCAM/KSA/KS1-4 antigen in mice. Cancer Gene Ther. 2002 Apr; 9(4):382-9. PMID: 11960289.
      View in: PubMed
    92. Papandréou MJ, Barbouche R, Guieu R, Kieny MP, Fenouillet E. The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step. Mol Pharmacol. 2002 Jan; 61(1):186-93. PMID: 11752220.
      View in: PubMed
    93. Price VL, Kieny MP. Vaccines for parasitic diseases. Curr Drug Targets Infect Disord. 2001 Nov; 1(3):315-24. PMID: 12455404.
      View in: PubMed
    94. BenAmmar-Ceccoli S, Humblot S, Crouzier R, Acres B, Kieny MP, Herlyn D, Pasquali JL, Martin T. Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth. Cancer Gene Ther. 2001 Oct; 8(10):815-26. PMID: 11687905.
      View in: PubMed
    95. Khatissian E, Monceaux V, Cumont MC, Kieny MP, Aubertin AM, Hurtrel B. Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef. J Virol. 2001 Feb; 75(3):1507-15. PMID: 11152522; PMCID: PMC114055.
    96. Scholl SM, Balloul JM, Le Goc G, Bizouarne N, Schatz C, Kieny MP, von Mensdorff-Pouilly S, Vincent-Salomon A, Deneux L, Tartour E, Fridman W, Pouillart P, Acres B. Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer. J Immunother. 2000 Sep-Oct; 23(5):570-80. PMID: 11001550.
      View in: PubMed
    97. Barbouche R, Decroly E, Kieny MP, Fenouillet E. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step. Virology. 2000 Jul 20; 273(1):169-77. PMID: 10891419.
      View in: PubMed
    98. Paul S, Snary D, Hoebeke J, Allen D, Balloul JM, Bizouarne N, Dott K, Geist M, Hilgers J, Kieny MP, Burchell J, Taylor-Papadimitriou J, Acres RB. Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment. Hum Gene Ther. 2000 Jul 01; 11(10):1417-28. PMID: 10910139.
      View in: PubMed
    99. Paul S, Bizouarne N, Dott K, Ruet L, Dufour P, Acres RB, Kieny MP. Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody. Cancer Gene Ther. 2000 Apr; 7(4):615-23. PMID: 10811480.
      View in: PubMed
    100. Acres B, Apostolopoulos V, Balloul JM, Wreschner D, Xing PX, Ali-Hadji D, Bizouarne N, Kieny MP, McKenzie IF. MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines. Cancer Immunol Immunother. 2000 Jan; 48(10):588-94. PMID: 10630311.
      View in: PubMed
    101. Czerkinsky C, Anjuere F, McGhee JR, George-Chandy A, Holmgren J, Kieny MP, Fujiyashi K, Mestecky JF, Pierrefite-Carle V, Rask C, Sun JB. Mucosal immunity and tolerance: relevance to vaccine development. Immunol Rev. 1999 Aug; 170:197-222. PMID: 10566152.
      View in: PubMed
    102. Paul S, Bizouarne N, Paul A, Price MR, Hansson GC, Kieny MP, Acres RB. Lack of evidence for an immunosuppressive role for MUC1. Cancer Immunol Immunother. 1999 Apr; 48(1):22-8. PMID: 10235485.
      View in: PubMed
    103. Slos P, Dutot P, Reymund J, Kleinpeter P, Prozzi D, Kieny MP, Delcour J, Mercenier A, Hols P. Production of cholera toxin B subunit in Lactobacillus. FEMS Microbiol Lett. 1998 Dec 01; 169(1):29-36. PMID: 9851032.
      View in: PubMed
    104. Coëffier E, Excler JL, Kieny MP, Meignier B, Moste C, Tartaglia J, Pialoux G, Salmon-Céron D, Leclerc C. Restricted specificity of anti-V3 antibodies induced in humans by HIV candidate vaccines. AIDS Res Hum Retroviruses. 1997 Nov 20; 13(17):1471-85. PMID: 9390746.
      View in: PubMed
    105. Dunn CS, Hurtrel B, Beyer C, Gloeckler L, Ledger TN, Moog C, Kieny MP, Mehtali M, Schmitt D, Gut JP, Kirn A, Aubertin AM. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1. AIDS Res Hum Retroviruses. 1997 Jul 20; 13(11):913-22. PMID: 9223407.
      View in: PubMed
    106. Rose KA, Stapleton G, Dott K, Kieny MP, Best R, Schwarz M, Russell DW, Björkhem I, Seckl J, Lathe R. Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proc Natl Acad Sci U S A. 1997 May 13; 94(10):4925-30. PMID: 9144166; PMCID: PMC24607.
    107. Perraut R, Chouteau P, Moog C, Bonnemains B, Kieny MP. Immunogenicity of HIV-1LAI gp160 and env peptides in squirrel monkey Saimiri sciureus using alumine and experimental adjuvants. Clin Exp Immunol. 1996 Dec; 106(3):434-41. PMID: 8973609; PMCID: PMC2200625.
    108. Fleury B, Janvier G, Pialoux G, Buseyne F, Robertson MN, Tartaglia J, Paoletti E, Kieny MP, Excler JL, Rivière Y. Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160. J Infect Dis. 1996 Oct; 174(4):734-8. PMID: 8843210.
      View in: PubMed
    109. Dunn CS, Beyer C, Kieny MP, Gloeckler L, Schmitt D, Gut JP, Kirn A, Aubertin AM. High viral load and CD4 lymphopenia in rhesus and cynomolgus macaques infected by a chimeric primate lentivirus constructed using the env, rev, tat, and vpu genes from HIV-1 Lai. Virology. 1996 Sep 15; 223(2):351-61. PMID: 8806570.
      View in: PubMed
    110. McCutchan FE, Artenstein AW, Sanders-Buell E, Salminen MO, Carr JK, Mascola JR, Yu XF, Nelson KE, Khamboonruang C, Schmitt D, Kieny MP, McNeil JG, Burke DS. Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol. 1996 Jun; 70(6):3331-8. PMID: 8648662; PMCID: PMC190203.
    111. Kaplan C, Morel-Kopp MC, Kieny MP, Kolbe H, Salmon P, Sicard D, Pialoux G, Meignier B, Excler JL, Plotkin S. Antiplatelet antibodies during the course of HIV-preventive vaccine trial. AIDS. 1996 Apr; 10(4):447-9. PMID: 8728055.
      View in: PubMed
    112. Salmon-Céron D, Excler JL, Sicard D, Blanche P, Finkielstzjen L, Gluckman JC, Autran B, Matthews TJ, Meignier B, Kieny MP, et al. Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteers. AIDS Res Hum Retroviruses. 1995 Dec; 11(12):1479-86. PMID: 8679292.
      View in: PubMed
    113. Girard M, Meignier B, Barré-Sinoussi F, Kieny MP, Matthews T, Muchmore E, Nara PL, Wei Q, Rimsky L, Weinhold K, et al. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J Virol. 1995 Oct; 69(10):6239-48. PMID: 7666524; PMCID: PMC189521.
    114. Boudet F, Keller H, Kieny MP, Thèze J. Single peptide and anti-idiotype based immunizations can broaden the antibody response against the variable V3 domain of HIV-1 in mice. Mol Immunol. 1995 May; 32(7):449-57. PMID: 7783749.
      View in: PubMed
    115. Herlyn D, Somasundaram R, Zaloudik J, Li W, Jacob L, Harris D, Kieny MP, Ricciardi R, Gonczol E, Sears H, et al. Cloned antigens and antiidiotypes. Hybridoma. 1995 Apr; 14(2):159-66. PMID: 7590774.
      View in: PubMed
    116. Abimiku AG, Franchini G, Tartaglia J, Aldrich K, Myagkikh M, Markham PD, Chong P, Klein M, Kieny MP, Paoletti E, et al. HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques. Nat Med. 1995 Apr; 1(4):321-9. PMID: 7585061.
      View in: PubMed
    117. Pialoux G, Excler JL, Rivière Y, Gonzalez-Canali G, Feuillie V, Coulaud P, Gluckman JC, Matthews TJ, Meignier B, Kieny MP, et al. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA. AIDS Res Hum Retroviruses. 1995 Mar; 11(3):373-81. PMID: 7598771.
      View in: PubMed
    118. Vogt G, le Grand R, Vaslin B, Boussin F, Auboyer MH, Rivière Y, Putkonen P, Sonigo P, Kieny MP, Girard M, et al. Heterologous HIV-2 challenge of rhesus monkeys immunized with recombinant vaccinia viruses and purified recombinant HIV-2 proteins. Vaccine. 1995 Feb; 13(2):202-8. PMID: 7625117.
      View in: PubMed
    119. Moulard M, Achstetter T, Kieny MP, Montagnier L, Bahraoui E. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor. Eur J Biochem. 1994 Oct 15; 225(2):565-72. PMID: 7957171.
      View in: PubMed
    120. Slos P, Speck D, Accart N, Kolbe HV, Schubnel D, Bouchon B, Bischoff R, Kieny MP. Recombinant cholera toxin B subunit in Escherichia coli: high-level secretion, purification, and characterization. Protein Expr Purif. 1994 Oct; 5(5):518-26. PMID: 7827509.
      View in: PubMed
    121. Robert-Guroff M, Louie A, Myagkikh M, Michaels F, Kieny MP, White-Scharf ME, Potts B, Grogg D, Reitz MS. Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization. J Virol. 1994 Jun; 68(6):3459-66. PMID: 7514675; PMCID: PMC236848.
    122. Herlyn D, Harris D, Zaloudik J, Sperlagh M, Maruyama H, Jacob L, Kieny MP, Scheck S, Somasundaram R, Hart E, et al. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients. J Immunother Emphasis Tumor Immunol. 1994 May; 15(4):303-11. PMID: 8061902.
      View in: PubMed
    123. Robertson MN, Buseyne F, Kieny MP, Rivière Y. Strain specificity of cell-mediated cytotoxic responses specific for the human immunodeficiency virus type 1 (HIV-1) envelope protein in seropositive donors: HIV-1Lai is more commonly recognized than HIV-1MN. J Infect Dis. 1994 Feb; 169(2):274-80. PMID: 7906289.
      View in: PubMed
    124. Acres B, Dott K, Stefani L, Kieny MP. Directed cytokine expression in tumour cells in vivo using recombinant vaccinia virus. Ther Immunol. 1994 Jan; 1(1):17-23. PMID: 7584475.
      View in: PubMed
    125. Herlyn D, Somasundaram R, Zaloudik J, Jacob L, Harris D, Kieny MP, Sears H, Mastrangelo M. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer. Cell Biophys. 1994; 24-25:143-53. PMID: 7736518.
      View in: PubMed
    126. Murphy E, Korber B, Georges-Courbot MC, You B, Pinter A, Cook D, Kieny MP, Georges A, Mathiot C, Barré-Sinoussi F, et al. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic. AIDS Res Hum Retroviruses. 1993 Oct; 9(10):997-1006. PMID: 8280481.
      View in: PubMed
    127. Gotch F, McAdam SN, Allsopp CE, Gallimore A, Elvin J, Kieny MP, Hill AV, McMichael AJ, Whittle HC. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. J Immunol. 1993 Sep 15; 151(6):3361-9. PMID: 7690804.
      View in: PubMed
    128. Taupin JL, Acres B, Dott K, Schmitt D, Kieny MP, Gualde N, Moreau JF. Immunogenicity of HILDA/LIF either in a soluble or in a membrane anchored form expressed in vivo by recombinant vaccinia viruses. Scand J Immunol. 1993 Sep; 38(3):293-301. PMID: 8356405.
      View in: PubMed
    129. Laurent-Crawford AG, Krust B, Rivière Y, Desgranges C, Muller S, Kieny MP, Dauguet C, Hovanessian AG. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses. 1993 Aug; 9(8):761-73. PMID: 8105835.
      View in: PubMed
    130. Acres RB, Hareuveni M, Balloul JM, Kieny MP. Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen. J Immunother Emphasis Tumor Immunol. 1993 Aug; 14(2):136-43. PMID: 8280702.
      View in: PubMed
    131. Fenouillet E, Jones I, Powell B, Schmitt D, Kieny MP, Gluckman JC. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain. J Virol. 1993 Jan; 67(1):150-60. PMID: 8093218; PMCID: PMC237347.
    132. Mehtali M, Munschy M, Ali-Hadji D, Kieny MP. A novel transgenic mouse model for the in vivo evaluation of anti-human immunodeficiency virus type 1 drugs. AIDS Res Hum Retroviruses. 1992 Dec; 8(12):1959-65. PMID: 1493046.
      View in: PubMed
    133. Kieny MP. [AIDS: vaccination against HIV]. Pathol Biol (Paris). 1992 Nov; 39(9):876. PMID: 1538917.
      View in: PubMed
    134. Fultz PN, Nara P, Barre-Sinoussi F, Chaput A, Greenberg ML, Muchmore E, Kieny MP, Girard M. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science. 1992 Jun 19; 256(5064):1687-90. PMID: 1609280.
      View in: PubMed
    135. Benichou S, Legrand R, Nakagawa N, Faure T, Traincard F, Vogt G, Dormont D, Tiollais P, Kieny MP, Madaule P. Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus. AIDS Res Hum Retroviruses. 1992 Jun; 8(6):1165-70. PMID: 1380263.
      View in: PubMed
    136. Girard M, Kieny MP, Barré-Sinoussi F, Nara P, Muchmore E, Fultz P. [Experimental vaccination against HIV-1 protects the chimpanzee against challenge with injections of infected lymphocytes]. Bull Acad Natl Med. 1992 Jun; 176(6):921-34; discussion 935. PMID: 1464038.
      View in: PubMed
    137. Michel F, Hoffenbach A, Froussard P, Langlade-Demoyen P, Kaczorek M, Kieny MP, Plata F. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins. AIDS Res Hum Retroviruses. 1992 Apr; 8(4):469-78. PMID: 1376136.
      View in: PubMed
    138. Hadida F, Parrot A, Kieny MP, Sadat-Sowti B, Mayaud C, Debre P, Autran B. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. J Clin Invest. 1992 Jan; 89(1):53-60. PMID: 1370302; PMCID: PMC442818.
    139. Guy B, Acres RB, Rivière Y, Kieny MP. The HIV Nef protein: facts and hypotheses. Res Virol. 1992 Jan-Feb; 143(1):34-7. PMID: 1565852.
      View in: PubMed
    140. Wiktor TJ, MacFarlan RI, Reagan KJ, Dietzschold B, Curtis PJ, Wunner WH, Kieny MP, Lathe R, Lecocq JP, Mackett M, et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. 1984. Biotechnology. 1992; 24:508-12. PMID: 1422063.
      View in: PubMed
    141. Winter N, Lagranderie M, Rauzier J, Timm J, Leclerc C, Guy B, Kieny MP, Gheorghiu M, Gicquel B. Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene. 1991 Dec 20; 109(1):47-54. PMID: 1756981.
      View in: PubMed
    142. Brochier B, Kieny MP, Costy F, Coppens P, Bauduin B, Lecocq JP, Languet B, Chappuis G, Desmettre P, Afiademanyo K, et al. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature. 1991 Dec 19-26; 354(6354):520-2. PMID: 1758494.
      View in: PubMed
    143. Van Bressem MF, De Meurichy J, Chappuis G, Spehner D, Kieny MP, Pastoret PP. Attempt to vaccinate orally harbour seals against phocid distemper. Vet Rec. 1991 Oct 19; 129(16):362. PMID: 1759340.
      View in: PubMed
    144. Neurath AR, Jiang S, Strick N, Kolbe H, Kieny MP, Muchmore E, Girard M. Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins. AIDS Res Hum Retroviruses. 1991 Oct; 7(10):813-23. PMID: 1720628.
      View in: PubMed
    145. Neurath AR, Strick N, Kolbe H, Kieny MP, Girard M, Jiang S. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)--II. Synthetic peptides linked to HIV-1 carrier proteins gag and nef. Mol Immunol. 1991 Sep; 28(9):965-73. PMID: 1717841.
      View in: PubMed
    146. Hareuveni M, Wreschner DH, Kieny MP, Dott K, Gautier C, Tomasetto C, Keydar I, Chambon P, Lathe R. Vaccinia recombinants expressing secreted and transmembrane forms of breast cancer-associated epithelial tumour antigen (ETA). Vaccine. 1991 Sep; 9(9):618-26. PMID: 1950095.
      View in: PubMed
    147. Dezutter-Dambuyant C, Schmitt DA, Dusserre N, Hanau D, Kolbe HV, Kieny MP, Cazenave JP, Schmitt D, Pasquali JL, Olivier R, et al. Interaction of human epidermal Langerhans cells with HIV-1 viral envelope proteins (gp 120 and gp 160s) involves a receptor-mediated endocytosis independent of the CD4 T4A epitope. J Dermatol. 1991 Jul; 18(7):377-92. PMID: 1724250.
      View in: PubMed
    148. Dezutter-Dambuyant C, Schmitt DA, Dusserre N, Hanau D, Kolbe HV, Kieny MP, Gazzolo L, Macé K, Pasquali JL, Olivier R. Trypsin-resistant gp120 receptors are upregulated on short-term cultured human epidermal Langerhans cells. Res Virol. 1991 Mar-Jun; 142(2-3):129-38. PMID: 1896637.
      View in: PubMed
    149. Guy B, Geist M, Dott K, Spehner D, Kieny MP, Lecocq JP. A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol. 1991 Mar; 65(3):1325-31. PMID: 1995946; PMCID: PMC239908.
    150. Meneguzzi G, Cerni C, Kieny MP, Lathe R. Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology. 1991 Mar; 181(1):62-9. PMID: 1847269.
      View in: PubMed
    151. Girard M, Kieny MP, Pinter A, Barre-Sinoussi F, Nara P, Kolbe H, Kusumi K, Chaput A, Reinhart T, Muchmore E, et al. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci U S A. 1991 Jan 15; 88(2):542-6. PMID: 1988952; PMCID: PMC50847.
    152. Nakagawa N, Nakagawa T, Acres B, Yasukawa K, Kieny MP. In vivo delivery of interleukin-6 using vaccinia virus: effects on T lymphocytes in nude mice. Eur Cytokine Netw. 1991 Jan-Feb; 2(1):11-6. PMID: 1873489.
      View in: PubMed
    153. Hareuveni M, Gautier C, Kieny MP, Wreschner D, Chambon P, Lathe R. Vaccination against tumor cells expressing breast cancer epithelial tumor antigen. Proc Natl Acad Sci U S A. 1990 Dec; 87(23):9498-502. PMID: 2251291; PMCID: PMC55194.
    154. Skern T, Bischoff R, Jallat S, Dott K, Ali-Hadji D, Clesse D, Kieny MP, Courtney M. Sulphation of hirudin in BHK cells. FEBS Lett. 1990 Nov 26; 275(1-2):36-8. PMID: 2261997.
      View in: PubMed
    155. Laurent AG, Hovanessian AG, Rivière Y, Krust B, Regnault A, Montagnier L, Findeli A, Kieny MP, Guy B. Production of a non-functional nef protein in human immunodeficiency virus type 1-infected CEM cells. J Gen Virol. 1990 Oct; 71 ( Pt 10):2273-81. PMID: 1977871.
      View in: PubMed
    156. Pasquali JL, Kieny MP, Kolbe H, Christmann D, Knapp AM. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency virus type 1 envelope glycoprotein. AIDS Res Hum Retroviruses. 1990 Sep; 6(9):1107-13. PMID: 1702300.
      View in: PubMed
    157. Nixon DF, Huet S, Rothbard J, Kieny MP, Delchambre M, Thiriart C, Rizza CR, Gotch FM, McMichael AJ. An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. AIDS. 1990 Sep; 4(9):841-5. PMID: 1701304.
      View in: PubMed
    158. Trottein F, Kieny MP, Verwaerde C, Torpier G, Pierce RJ, Balloul JM, Schmitt D, Lecocq JP, Capron A. Molecular cloning and tissue distribution of a 26-kilodalton Schistosoma mansoni glutathione S-transferase. Mol Biochem Parasitol. 1990 Jun; 41(1):35-44. PMID: 2385266.
      View in: PubMed
    159. Desmettre P, Languet B, Chappuis G, Brochier B, Thomas I, Lecocq JP, Kieny MP, Blancou J, Aubert M, Artois M, et al. Use of vaccinia rabies recombinant for oral vaccination of wildlife. Vet Microbiol. 1990 Jun; 23(1-4):227-36. PMID: 2205969.
      View in: PubMed
    160. Meneguzzi G, Kieny MP, Lecocq JP, Chambon P, Cuzin F, Lathe R. Vaccinia recombinants expressing early bovine papilloma virus (BPV1) proteins: retardation of BPV1 tumour development. Vaccine. 1990 Jun; 8(3):199-204. PMID: 2163573.
      View in: PubMed
    161. Guy B, Rivière Y, Dott K, Regnault A, Kieny MP. Mutational analysis of the HIV nef protein. Virology. 1990 Jun; 176(2):413-25. PMID: 2111956.
      View in: PubMed
    162. Schmitt D, Dezutter-Dambuyant C, Hanau D, Kolbe HV, Kieny MP, Cazenave JP, Thivolet J. In vitro binding and internalization of HIV envelope glycoproteins by human epidermal Langerhans cells does not require the CD4-gp120-binding site. Res Virol. 1990 Mar-Apr; 141(2):209-15. PMID: 1693220.
      View in: PubMed
    163. Kieny MP, Gautier C, Tomasetto C, Kuhn I, Hareuveni M, Clertant P, Lathe R. Vaccination against polyoma virus (PyV) tumors using vaccinia-PyV recombinants: a major tumor-specific transplantation antigen (TSTA) epitope resides within the C-terminal segment of middle-T protein. Int J Cancer. 1990 Jan 15; 45(1):185-9. PMID: 1688831.
      View in: PubMed
    164. Guy B, Acres B, Kieny MP, Lecocq JP. DNA binding factors that bind to the negative regulatory element of the human immunodeficiency virus-1: regulation by nef. J Acquir Immune Defic Syndr. 1990; 3(8):797-809. PMID: 2195154.
      View in: PubMed
    165. Kieny MP. Structure and regulation of the human AIDS virus. J Acquir Immune Defic Syndr. 1990; 3(4):395-402. PMID: 2179526.
      View in: PubMed
    166. McChesney M, Tanneau F, Regnault A, Sansonetti P, Montagnier L, Kieny MP, Rivière Y. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence. Eur J Immunol. 1990 Jan; 20(1):215-20. PMID: 2106442.
      View in: PubMed
    167. Thomas I, Brochier B, Languet B, Blancou J, Peharpre D, Kieny MP, Desmettre P, Chappuis G, Pastoret PP. Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route. J Gen Virol. 1990 Jan; 71 ( Pt 1):37-42. PMID: 2406370.
      View in: PubMed
    168. Meneguzzi G, Lathe R, Kieny MP, Vogt N. The E2 trans-activating protein of bovine papillomavirus type 1 (BPV1) is serine-phosphorylated in vivo. Oncogene. 1989 Nov; 4(11):1285-90. PMID: 2554235.
      View in: PubMed
    169. Brochier B, Blancou J, Thomas I, Languet B, Artois M, Kieny MP, Lecocq JP, Costy F, Desmettre P, Chappuis G, et al. Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming species. J Wildl Dis. 1989 Oct; 25(4):540-7. PMID: 2681844.
      View in: PubMed
    170. Kolbe HV, Jaeger F, Lepage P, Roitsch C, Lacaud G, Kieny MP, Sabatie J, Brown SW, Lecocq JP, Girard M. Isolation of recombinant partial gag gene product p18 (HIV-1Bru) from Escherichia coli. J Chromatogr. 1989 Aug 04; 476:99-112. PMID: 2674178.
      View in: PubMed
    171. Brochier BM, Blancou J, Aubert MF, Kieny MP, Desmettre P, Pastoret PP. Interaction between rabies infection and oral administration of vaccinia-rabies recombinant virus to foxes (Vulpes vulpes). J Gen Virol. 1989 Jun; 70 ( Pt 6):1601-4. PMID: 2732723.
      View in: PubMed
    172. Riviere Y, Tanneau-Salvadori F, Regnault A, Lopez O, Sansonetti P, Guy B, Kieny MP, Fournel JJ, Montagnier L. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol. 1989 May; 63(5):2270-7. PMID: 2522999; PMCID: PMC250645.
    173. Rautmann G, Kieny MP, Brandely R, Dott K, Girard M, Montagnier L, Lecocq JP. HIV-1 core proteins expressed from recombinant vaccinia viruses. AIDS Res Hum Retroviruses. 1989 Apr; 5(2):147-57. PMID: 2713165.
      View in: PubMed
    174. Van Eendenburg JP, Yagello M, Girard M, Kieny MP, Lecocq JP, Muchmore E, Fultz PN, Riviere Y, Montagnier L, Gluckman JC. Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses. AIDS Res Hum Retroviruses. 1989 Feb; 5(1):41-50. PMID: 2470398.
      View in: PubMed
    175. Schmitt D, Dezutter-Dambuyant C, Hanau D, Schmitt DA, Kolbe HV, Kieny MP, Cazenave JP, Thivolet J. [HIV envelope proteins are bound by human epidermal Langerhans cells by a binding site which differs from the site on the CD4 molecule, and are internalized by receptor endocytosis]. C R Acad Sci III. 1989; 308(10):269-75. PMID: 2543485.
      View in: PubMed
    176. Rivière Y, Tanneau-Salvadori F, Regnault A, Lopez O, Sansonetti P, Guy B, Kieny MP, Fournel JJ, Montagnier L. Multiple cytotoxic effector cells are induced by infection with the human immunodeficiency virus. Res Immunol. 1989 Jan; 140(1):110-5; discussion 121. PMID: 2657908.
      View in: PubMed
    177. Guizani I, Kieny MP, Lathe R, Clertant P. Characterization of polyoma virus early proteins expressed from vaccinia virus recombinants. Gene. 1988 Dec 15; 73(1):163-73. PMID: 2977356.
      View in: PubMed
    178. Michel F, Hoffenbach A, Langlade-Demoyen P, Guy B, Girard M, Lecocq JP, Wain-Hobson S, Kieny MP, Plata F. HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus. Eur J Immunol. 1988 Dec; 18(12):1917-24. PMID: 2905993.
      View in: PubMed
    179. Salmon P, Olivier R, Riviere Y, Brisson E, Gluckman JC, Kieny MP, Montagnier L, Klatzmann D. Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication. J Exp Med. 1988 Dec 01; 168(6):1953-69. PMID: 3264318; PMCID: PMC2189155.
    180. Pastoret PP, Brochier B, Languet B, Thomas I, Paquot A, Bauduin B, Kieny MP, Lecocq JP, De Bruyn J, Costy F, et al. First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus. Vet Rec. 1988 Nov 05; 123(19):481-3. PMID: 3201693.
      View in: PubMed
    181. Kieny MP, Blancou J, Lathe R, Pastoret PP, Soulebot JP, Desmettre P, Lecocq JP. Development of animal recombinant DNA vaccine and its efficacy in foxes. Rev Infect Dis. 1988 Nov-Dec; 10 Suppl 4:S799-802. PMID: 3206090.
      View in: PubMed
    182. Brochier BM, Languet B, Blancou J, Kieny MP, Lecocq JP, Costy F, Desmettre P, Pastoret PP. Use of recombinant vaccinia-rabies virus for oral vaccination of fox cubs (Vulpes vulpes, L) against rabies. Vet Microbiol. 1988 Oct; 18(2):103-8. PMID: 3218072.
      View in: PubMed
    183. Kieny MP, Lathe R, Rivière Y, Dott K, Schmitt D, Girard M, Montagnier L, Lecocq J. Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng. 1988 Sep; 2(3):219-25. PMID: 3237686.
      View in: PubMed
    184. Clertant P, Kieny MP, Lecocq JP, Guizani I, Chambon P, Cuzin F, Lathe R. Recombinant polyoma--vaccinia viruses: T antigen expression vectors and anti-tumor immunization agents. Biochimie. 1988 Aug; 70(8):1075-87. PMID: 2852508.
      View in: PubMed
    185. Khalife J, Guy B, Capron M, Kieny MP, Ameisen JC, Montagnier L, Lecocq JP, Capron A. Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Res Hum Retroviruses. 1988 Feb; 4(1):3-9. PMID: 3163253.
      View in: PubMed
    186. Kieny M, Boutineau AM, Pautou MP, Goetinck PF. Muscular dysgenesis in fowl: ultrastructural study of skeletal muscles in the crooked neck dwarf (cn/cn) mutant. Biol Struct Morphog. 1988; 1(1):15-27. PMID: 3401519.
      View in: PubMed
    187. Kieny M, Mauger A, Chevallier A, Pautou MP. Origin and development of avian skeletal musculature. Reprod Nutr Dev. 1988; 28(3B):673-86. PMID: 3055100.
      View in: PubMed
    188. Pastoret PP, Blancou J, Brochier B, Thomas I, Paquot A, Debruyn J, Costy F, Wolff F, Kieny MP, Languet B, et al. [Experience with antirabies vaccination of foxes using the oral route coordinated among several European countries and perspectives on the use of recombinant vaccinia-rabies virus]. Parassitologia. 1988 Jan-Apr; 30(1):149-54. PMID: 3268767.
      View in: PubMed
    189. Guy B, Kieny MP, Riviere Y, Le Peuch C, Dott K, Girard M, Montagnier L, Lecocq JP. HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature. 1987 Nov 19-25; 330(6145):266-9. PMID: 3118220.
      View in: PubMed
    190. Lathe R, Kieny MP, Gerlinger P, Clertant P, Guizani I, Cuzin F, Chambon P. Tumour prevention and rejection with recombinant vaccinia. Nature. 1987 Apr 30-May 6; 326(6116):878-80. PMID: 3033512.
      View in: PubMed
    191. Kieny MP, Desmettre P, Soulebot JP, Lathe R. Rabies vaccine: traditional and novel approaches. Prog Vet Microbiol Immunol. 1987; 3:73-111. PMID: 3078836.
      View in: PubMed
    192. Blancou J, Kieny MP, Lathe R, Lecocq JP, Pastoret PP, Soulebot JP, Desmettre P. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature. 1986 Jul 24-30; 322(6077):373-5. PMID: 3736663.
      View in: PubMed
    193. Kieny MP, Lathe R, Drillien R, Spehner D, Skory S, Schmitt D, Wiktor T, Koprowski H, Lecocq JP. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature. 1984 Nov 8-14; 312(5990):163-6. PMID: 6548799.
      View in: PubMed
    194. Wiktor TJ, Macfarlan RI, Reagan KJ, Dietzschold B, Curtis PJ, Wunner WH, Kieny MP, Lathe R, Lecocq JP, Mackett M, et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A. 1984 Nov; 81(22):7194-8. PMID: 6095272; PMCID: PMC392104.
    195. Lathe R, Kieny MP, Skory S, Lecocq JP. Linker tailing: unphosphorylated linker oligonucleotides for joining DNA termini. DNA. 1984; 3(2):173-82. PMID: 6327214.
      View in: PubMed
    196. Lathe RF, Kieny MP, Schmitt D, Curtis P, Lecocq JP. M13 bacteriophage vectors for the expression of foreign proteins in Escherichia coli: the rabies glycoprotein. J Mol Appl Genet. 1984; 2(4):331-42. PMID: 6330261.
      View in: PubMed
    197. Kieny MP, Lathe R, Lecocq JP. New versatile cloning and sequencing vectors based on bacteriophage M13. Gene. 1983 Dec; 26(1):91-9. PMID: 6323254.
      View in: PubMed
    Kieny's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description